Role of CMA failure in NASH progression to Hepatocellular Carcinoma
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
批准号:
10380118
负责人:
Esperanza Arias-Perez
金额:
$37.8万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-01 至 2024-04-30
关键词:
AgingAutomobile DrivingAutophagocytosisCancer EtiologyCell DeathCell physiologyCellsCessation of lifeChemicalsClinicalDataDeveloped CountriesDevelopmentDiabetes MellitusDiagnosisDietary FatsDisease ProgressionExposure toFailureFatty LiverFunctional disorderGenetic EngineeringGenetic ModelsGoalsHepaticHepatocarcinogenesisHepatocyteHomeostasisHyperlipidemiaImageImmuneIn VitroIncidenceIndividualInterventionKupffer CellsLipidsLiverLiver diseasesLysosomesMaintenanceMalignant - descriptorMalignant neoplasm of liverMammalian CellMediatingMetabolic PathwayModelingMolecularMolecular ChaperonesMusObesityOncogenicPathologyPathway interactionsPatientsPersonsPrimary carcinoma of the liver cellsProteinsQuality ControlRecyclingRegulationReporterRiskRisk FactorsRoleStimulusSystemT-Cell ActivationT-LymphocyteTP53 geneTestingTherapeuticTransgenic MiceUp-RegulationWorkbasecancer typecatalystcell transformationcell typechemical geneticsdietaryeffective interventionfunctional disabilityglucose metabolismin vivolipid metabolismliver cancer modellysosomal proteinsmouse modelnon-alcoholic fatty livernon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovel strategiesnovel therapeutic interventionpreservationpreventpreventive interventionproteostasisstellate celltumortumor growthtumorigenesis
中文摘要
摘要
这项建议调查了有缺陷的维持蛋白质稳态(蛋白质稳态)在
脂肪变性的肝脏,进展为肝细胞癌(HCC)。系统中的扰动
在肝细胞癌中观察到了维持肝脏蛋白平衡,但在肝细胞癌中蛋白平衡丧失的程度
肝脂肪变性是肝细胞癌发生的危险因素,目前尚不清楚。我们将专注于监护人-
介导自噬(CMA),一种介导胞浆选择性降解的蛋白质质量控制系统
溶酶体中的蛋白质。肝脏CMA缺陷导致肝脏葡萄糖改变导致肝骨病
和脂类新陈代谢以及整体能量学。我们最近对CMA和CMA之间相互作用的研究
肿瘤发生研究表明:(1)CMA失败后具有抗肿瘤作用,如
在衰老、糖尿病或脂肪变性的肝脏中观察到,有利于恶变,以及患有肝脏CMA的小鼠
阻断形成自发性肿瘤;(Ii)CMA是转化细胞中维持肿瘤生长所必需的,因为:
(I)转化细胞最大限度地上调CMA;(Ii)阻断转化细胞中的CMA可减少增殖
并诱导细胞死亡和(Iii)阻断预先形成的肿瘤中的CMA抑制肿瘤生长并导致
肿瘤缩小。
我们认为:1)脂肪变性肝脏中CMA的逐渐减少促进了肝脏的恶性转化。
促肿瘤刺激的背景和2)在脂肪变性中恢复正常CMA活性的干预
肝脏可以防止或减缓肝细胞癌的进展。
为了验证这一假设,我们打算:1)确定CMA失败对致癌转化的贡献
在肝癌中;2)确定CMA失败对肝癌进展的肝脏和免疫细胞类型的特异性贡献;3)
评估CMA的化学和遗传上调作为预防措施可能产生的有益影响
干预NASH导致肝细胞癌进展。
意义:这项研究将阐明CMA的功能损害如何在肝脏病理中起作用,以及它是否
增加脂肪变性肝脏中的肝细胞癌风险。我们的发现可能有助于开发新的方法来保护
脂肪变性的肝脏动态平衡和功能,并降低其对肝细胞癌的风险。
英文摘要
ABSTRACT
This proposal investigates the contribution of defective maintenance of protein homeostasis (proteostasis) in
the steatotic liver, to the progression to hepatocellular carcinoma (HCC). Disturbances in the systems that
maintain liver proteostasis have been observed in HCC, but the extent to which loss of proteostasis in the
steatotic liver constitutes a risk factor for development of HCC remains unknown. We will focus in chaperone-
mediated autophagy (CMA), a protein quality control system that mediates selective degradation of cytosolic
proteins in lysosomes. Defective CMA in liver leads to hepatosteatosis due to alterations in hepatic glucose
and lipid metabolism and in overall energetics. Our recent studies on the interplay between CMA and
oncogenesis have shown that: (I) CMA has an anti-oncogenic effect since failure of CMA, such as that
observed in aging, diabetes or the steatotic liver, favors malignant transformation, and mice with hepatic CMA
blockage develop spontaneous tumors; (II) CMA is required in transformed cells to sustain tumor growth since:
(i) transformed cells maximally upregulate CMA, (ii) blockage of CMA in transformed cells reduces proliferation
and induces cell death and (iii) blockage of CMA in pre-formed tumors inhibits tumor growth and results in
tumor shrinkage.
We propose that 1) the gradual decline of CMA in the steatotic liver facilitates malignant transformation in the
context of a pro-oncogenic stimulus and that 2) interventions to restore normal CMA activity in the steatotic
liver will prevent or slow down progression to HCC.
To test this hypothesis, we intend to: 1) determine the contribution of CMA failure to oncogenic transformation
in HCC; 2) identify the liver and immune cell type-specific contribution of CMA failure to HCC progression; 3)
evaluate the possible beneficial impact of chemical and genetic upregulation of CMA as a preventive
intervention against NASH to HCC progression.
Significance: This study will elucidate how functional impairment of CMA contributes to liver pathology and if it
increases HCC risk in steatotic liver. Our findings could help in developing new approaches to preserve
steatotic liver homeostasis and function and reduce its risk to HCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
-
批准号:10601037
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2020
-
负责人:Esperanza Arias-Perez
-
依托单位:
海外基金